Treatment outcomes and next-generation sequencing of a rare malignancy - urachal carcinoma: case report and literature review

UrC is a rare malignancy with uncertain pathogenesis. The main symptoms include gross hematuria, abdominal pain, and an abdominal mass. The lack of comprehensive clinical analysis necessitates selecting an optimal therapeutic strategy for each patient. Here, we present a comprehensive review of the clinical manifestations, diagnosis, and treatment of UrC, illustrated with a case successfully managed through surgical intervention and adjuvant chemoradiotherapy. Meanwhile, the analysis of NGS detected two tumor-specific mutated genes: MYC (gene amplification, CN: 59.5) and FLT1 (missense mutation, c.1061G>A (p.R354Q), abundance: 2.1%). These findings may provide insights into tumor growth and guide therapeutic strategies.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-04-21
DOI
https://doi.org/10.3389/fonc.2026.1744925
Primary Topic
Urinary and Genital Oncology Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Treatment outcomes and next-generation sequencing of a rare malignancy - urachal carcinoma: case report and literature review

Chenhui Cao, Xinhao Peng, Dan Shang, Chuan Xu et al.
Frontiers in Oncology
Urinary and Genital Oncology Studies
article

Treatment outcomes and next-generation sequencing of a rare malignancy - urachal carcinoma: case report and literature review

Chenhui Cao, Xinhao Peng, Dan Shang, Chuan Xu, Senlin Xu, Linlin Zheng, Hong Wu, Jie Chen, Tian Tan
article en

Abstract

UrC is a rare malignancy with uncertain pathogenesis. The main symptoms include gross hematuria, abdominal pain, and an abdominal mass. The lack of comprehensive clinical analysis necessitates selecting an optimal therapeutic strategy for each patient. Here, we present a comprehensive review of the clinical manifestations, diagnosis, and treatment of UrC, illustrated with a case successfully managed through surgical intervention and adjuvant chemoradiotherapy. Meanwhile, the analysis of NGS detected two tumor-specific mutated genes: MYC (gene amplification, CN: 59.5) and FLT1 (missense mutation, c.1061G>A (p.R354Q), abundance: 2.1%). These findings may provide insights into tumor growth and guide therapeutic strategies.

Frontiers in OncologyVol. 16
Army Medical University (CN), Third People's Hospital of Chengdu (CN), Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital (CN), Sichuan Cancer Hospital (CN), Southwest Hospital (CN), Southwest Jiaotong University (CN), Chengdu University of Traditional Chinese Medicine (CN)
Good health and well-being
Openalex Percentile: Top 22%
Urinary and Genital Oncology Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.